nanomedicines for the prevention and...
| |
nanomedicines for the prevention and treatment of infectious diseases
|
|
|
antibody-drug conjugates
|
systems pharmacology and pharmacodyn...
| |
systems pharmacology and pharmacodynamics
|
hydrophilic matrix tablets for oral ...
| |
hydrophilic matrix tablets for oral controlled release
|
development of biopharmaceutical dru...
| |
development of biopharmaceutical drug-device products
|
essentials of industrial pharmacy
| |
essentials of industrial pharmacy
|
principles and practices of lyophili...
| |
principles and practices of lyophilization in product development and manufacturing
|
fda bioequivalence standards
| |
fda bioequivalence standards
|
science and regulations of naturally...
| |
science and regulations of naturally derived complex drugs
|
|
|
peptide therapeutics
|
formulating poorly water soluble drugs
| |
formulating poorly water soluble drugs
|
translating molecular biomarkers int...
| |
translating molecular biomarkers into clinical assays
|
pharmaco-imaging in drug and biologi...
| |
pharmaco-imaging in drug and biologics development
|
quality by design for biopharmaceuti...
| |
quality by design for biopharmaceutical drug product development
|
non-biological complex drugs
| |
non-biological complex drugs
|
bioequivalence requirements in vario...
| |
bioequivalence requirements in various global jurisdictions
|
translating molecules into medicines
| |
translating molecules into medicines
|
|
|
regulated bioanalysis
|
mucosal delivery of drugs and biolog...
| |
mucosal delivery of drugs and biologics in nanoparticles
|
|
|
biobetters
|